Open AccessEvaluation of the use of piperacillin/tazobactam (Tazocin®) at Hamad General Hospital, Qatar: are there unjustified prescriptions?
Author(s) -
Fahmi Yousef Khan
Publication year - 2012
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s27965
Subject(s) - medicine , piperacillin , piperacillin/tazobactam , tazobactam , medical prescription , retrospective cohort study , intensive care medicine , intensive care unit , antibiotics , emergency medicine , pharmacology , microbiology and biotechnology , genetics , bacteria , pseudomonas aeruginosa , biology
The aim of this study was to evaluate the appropriateness of piperacillin/tazobactam (Tazocin(®); Pfizer, New York, NY) usage in our hospital.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom